50 related articles for article (PubMed ID: 27663271)
1. Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30.
Xu X; Narni-Mancinelli E; Cantoni C; Li Y; Guia S; Gauthier L; Chen Q; Moretta A; Vély F; Eisenstein E; Rangarajan S; Vivier E; Mariuzza RA
J Mol Biol; 2016 Nov; 428(22):4457-4466. PubMed ID: 27663271
[TBL] [Abstract][Full Text] [Related]
2. B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors.
Kaifu T; Escalière B; Gastinel LN; Vivier E; Baratin M
Cell Mol Life Sci; 2011 Nov; 68(21):3531-9. PubMed ID: 21877119
[TBL] [Abstract][Full Text] [Related]
3. Affinity Maturation of the Natural Ligand (B7-H6) for Natural Cytotoxicity Receptor NKp30 by Yeast Surface Display.
Zielonka S; Krah S; Arras P; Lipinski B; Zimmermann J; Boje AS; Klausz K; Peipp M; Pekar L
Methods Mol Biol; 2023; 2681():231-248. PubMed ID: 37405651
[TBL] [Abstract][Full Text] [Related]
4. All-trans retinoic acid induces leukemia resistance to NK cell cytotoxicity by down-regulating B7-H6 expression via c-Myc signaling.
Cao G; Cheng Y; Zheng X; Wei H; Tian Z; Sun R; Sun H
Cancer Commun (Lond); 2021 Jan; 41(1):51-61. PubMed ID: 34236140
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression.
Kim N; Yi E; Lee E; Park HJ; Kim HS
Front Immunol; 2024; 15():1388018. PubMed ID: 38698855
[TBL] [Abstract][Full Text] [Related]
6. Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia.
Baragaño Raneros A; Rodriguez RM; Bernardo Flórez A; Palomo P; Colado E; Minguela A; Suárez Álvarez B; López-Larrea C
Oncoimmunology; 2021 Mar; 10(1):1897294. PubMed ID: 33796404
[TBL] [Abstract][Full Text] [Related]
7. NKp30 - A prospective target for new cancer immunotherapy strategies.
Pinheiro PF; Justino GC; Marques MM
Br J Pharmacol; 2020 Oct; 177(20):4563-4580. PubMed ID: 32737988
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of N-linked glycosylation impairs immune function of B7-H6.
Chen H; Zhang Y; Shen Y; Jiang L; Zhang G; Zhang X; Xu Y; Fu F
Front Immunol; 2023; 14():1255667. PubMed ID: 38035117
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of B7-H6 protein expression in astrocytoma.
Guo JG; Guo CC; He ZQ; Liu ZG; Wang Y; Mou YG
Onco Targets Ther; 2016; 9():3291-7. PubMed ID: 27330308
[TBL] [Abstract][Full Text] [Related]
10. The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance.
Kilian M; Friedrich MJ; Lu KH; Vonhören D; Jansky S; Michel J; Keib A; Stange S; Hackert N; Kehl N; Hahn M; Habel A; Jung S; Jähne K; Sahm F; Betge J; Cerwenka A; Westermann F; Dreger P; Raab MS; Meindl-Beinker NM; Ebert M; Bunse L; Müller-Tidow C; Schmitt M; Platten M
Sci Immunol; 2024 May; 9(95):eadj7970. PubMed ID: 38701193
[TBL] [Abstract][Full Text] [Related]
11. Large remodeling of the Myc-induced cell surface proteome in B cells and prostate cells creates new opportunities for immunotherapy.
Chen W; Mou KY; Solomon P; Aggarwal R; Leung KK; Wells JA
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33483421
[TBL] [Abstract][Full Text] [Related]
12. A Platform for Extracellular Interactome Discovery Identifies Novel Functional Binding Partners for the Immune Receptors B7-H3/CD276 and PVR/CD155.
Husain B; Ramani SR; Chiang E; Lehoux I; Paduchuri S; Arena TA; Patel A; Wilson B; Chan P; Franke Y; Wong AW; Lill JR; Turley SJ; Gonzalez LC; Grogan JL; Martinez-Martin N
Mol Cell Proteomics; 2019 Nov; 18(11):2310-2323. PubMed ID: 31308249
[TBL] [Abstract][Full Text] [Related]
13. A membrane protein display platform for receptor interactome discovery.
Cao S; Peterson SM; Müller S; Reichelt M; McRoberts Amador C; Martinez-Martin N
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34531301
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin ligases in oncogenic transformation and cancer therapy.
Senft D; Qi J; Ronai ZA
Nat Rev Cancer; 2018 Feb; 18(2):69-88. PubMed ID: 29242641
[TBL] [Abstract][Full Text] [Related]
15. Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT).
Deuss FA; Gully BS; Rossjohn J; Berry R
J Biol Chem; 2017 Jul; 292(27):11413-11422. PubMed ID: 28515320
[TBL] [Abstract][Full Text] [Related]
16. Immunological role and underlying mechanisms of B7-H6 in tumorigenesis.
Hu Y; Zeng T; Xiao Z; Hu Q; Li Y; Tan X; Yue H; Wang W; Tan H; Zou J
Clin Chim Acta; 2020 Mar; 502():191-198. PubMed ID: 31904350
[TBL] [Abstract][Full Text] [Related]
17. Expression of a novel immune checkpoint B7-H6 ligand in human small cell lung cancer.
Zhang X; Xie W; Wang Z; Song S; Qin Y; Zhang F; Chen F; Cai L
Ann Transl Med; 2020 May; 8(9):589. PubMed ID: 32566616
[TBL] [Abstract][Full Text] [Related]
18. The immunosuppressive microenvironment and immunotherapy in human glioblastoma.
Zhang X; Zhao L; Zhang H; Zhang Y; Ju H; Wang X; Ren H; Zhu X; Dong Y
Front Immunol; 2022; 13():1003651. PubMed ID: 36466873
[TBL] [Abstract][Full Text] [Related]
19. Tumor Marker B7-H6 Bound to the Coiled Coil Peptide-Polymer Conjugate Enables Targeted Therapy by Activating Human Natural Killer Cells.
Kalousková B; Skořepa O; Cmunt D; Abreu C; Krejčová K; Bláha J; Sieglová I; Král V; Fábry M; Pola R; Pechar M; Vaněk O
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829829
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
